Skip to content

Impact of a multidisciplinary family-integrated educational model on treatment adherence, self-care behaviours and blood pressure control in elderly chinese patients with hypertension

The impact of a multidisciplinary family-integrated educational model on treatment adherence, self-care behaviours and blood pressure control in elderly chinese patients with hypertension: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13397152
Enrollment
120
Registered
2026-03-27
Start date
2021-01-06
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment adherence, self-care behaviours and blood pressure control in elderly chinese patients with hypertension Other

Interventions

Participants will be randomised to an experimental and a control group at a 1:1 ratio using a computer-generated randomisation sequence created by an independent statistician using SAS 9.4 software (I
(2) dietary guidance (limit sodium to =6 g/day, reduce animal fat, increase vegetable/protein intake)
(3) training on strict medication regimen compliance
(4) lifestyle advice on exercise, smoking cessation, alcohol consumption of =50 g/day and stress management
and (5) 20-minute phone calls (biweekly) and 60-minute home visits (monthly) for 6 months. Intervention group The experimental group underwent a 6-month multidisciplinary MUST enhancement programme.
the urger (family caregiver) will monitor compliance, co-learn with the patient and reported BP fluctuations
the self-manager (patient) will collaborate to master disease knowledge and enhance self-care
and the educator (nurse) will serve as an advanced practice leader, co-directing care planning, independently monitoring clinical data, evaluating treatment efficacy and dynamically adjusting educatio

Sponsors

Hainan Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Exhibited stabilised BP (<140/90 mmHg for =1 month) while on a consistent antihypertensive medication regimen, defined as no changes in drug class, dosage or frequency during the 4 weeks preceding enrolment and throughout the 6-month intervention period. 2. Adequate family support was defined as having at least one literate adult family member available for =75% of sessions.

Exclusion criteria

Exclusion criteria: 1. Secondary hypertension 2. Sefractory hypertension 3. Severe hepatic or renal dysfunction 4. Malignancy 5. Cognitive impairment (i.e. a mini-mental state examination [s mmse] score of <24) and living alone or being illiterate.

Countries

China

Contacts

Public ContactQianqian Liu
liuqq_liu2505@126.com+86 18934506226

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 17, 2026